Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo

Fig. 5

Expression of select genes to validate RNA-seq data from tumors of R-ketorolac treated mice relative to placebo. Gene expression levels from tumors obtained from placebo control and R-ketorolac treated mice were determined by qPCR as described in Methods. Values represent relative expression for R-ketorolac compared to placebo (1.0). n = 3. * indicates p-value ≤0.05, ** indicates p-value ≤0.01, *** indicates p-value ≤0.001, and **** indicates p-value ≤0.0001 using one-way ANOVA, followed by Dunnett’s multiple comparisons test

Back to article page
\